医学
内科学
甲状腺
抗甲状腺自身抗体
甲状腺功能不全
胃肠病学
甲状腺炎
甲状腺功能
甲状腺癌
封锁
内分泌学
抗体
自身抗体
免疫学
受体
作者
Tomoko Kobayashi,Shintaro Iwama,Ayana Yamagami,Yoshinori Yasuda,Takayuki Okuji,Masaaki Ito,Xin Zhou,Masahiko Ando,Takeshi Onoue,Takashi Miyata,Mariko Sugiyama,Daisuke Hagiwara,Hidetaka Suga,Ryoichi Banno,Tetsunari Hase,Masahiro Morise,Takanori Ito,Toyone Kikumori,Megumi Inoue,Yukio Ando
标识
DOI:10.1210/clinem/dgac467
摘要
BACKGROUND: Thyroid dysfunction is frequently caused by treatment with antiprogrammed cell death-1 ligand 1 antibodies (PD-L1-Abs) and anticancer drugs, including ramucirumab (RAM) and multitargeted tyrosine kinase inhibitors (multi-TKIs), which are often used prior to PD-L1-Ab treatment in cancer patients. METHODS: A total of 148 patients treated with PD-L1-Abs were evaluated for antithyroid antibodies at baseline and for thyroid function every 6 weeks for 24 weeks after treatment initiation and then were observed until the visits stopped. RESULTS: Of the 148 patients, 15 (10.1%) developed thyroid dysfunction after PD-L1-Ab treatment (destructive thyroiditis in 8 and hypothyroidism without preceding thyrotoxicosis in 7). The prevalence of an elevated thyroid-stimulating hormone (TSH) level at baseline (3/15 [20.0%] vs 4/133 [3.0%], P < .05), positive antithyroglobulin antibodies (TgAbs) at baseline (4/15 [26.7%] vs 5/133 [3.8%], P < .05) and prior treatment with RAM or multi-TKIs (3/15 [20.0%] vs 5/133 [3.8%], P < .05) were significantly higher in patients with vs without thyroid dysfunction. In a multivariate analysis, elevated TSH level at baseline, TgAb positivity at baseline, and prior treatment with RAM or multi-TKIs were significantly associated with the development of thyroid dysfunction, with ORs of 7.098 (95% CI 1.154-43.638), 11.927 (95% CI 2.526-56.316), and 8.476 (95% CI 1.592-45.115), respectively. CONCLUSION: The results of this real-world study suggest that the risk of thyroid dysfunction induced by PD-L1-Abs can be predicted by the TSH level at baseline, TgAb positivity at baseline, and prior treatment with RAM or multi-TKIs.
科研通智能强力驱动
Strongly Powered by AbleSci AI